- Type 2 DM:
- PO 100mg once weekly
Tablet:
- 50mg
- 100mg
- Can be taken as monotherapy or in combination with other antidiabetic medications.
- Taken without regard to meals
DPP-4 inhibitor
It increases the levels of incretin hormones (GLP-1 and GIP), which regulate insulin secretion in response to meals and inhibit glucagon release. This leads to improved blood sugar control by increasing insulin production and reducing glucose production in the liver.
- Nasopharyngitis
- Headache
- Upper respiratory tract infection
- Hypersensitivity to trelagliptin or any component of the formulation.
- History of pancreatitis.
- Insulin
- Sulfonylureas
- Rifampin
Drug Status
Availability | Prescription only |
Pregnancy | Contraindicated |
Breastfeeding | Contraindicated |
Schedule | Not controlled |
BRAND NAME | STRENGTH | FORMULATION | PACK SIZE | MANUFACTURER | DISTRIBUTOR |
---|---|---|---|---|---|
Trelaz | 50mg | Tablet | 4’s | Galaxy | Galaxy |
Trelaz | 100mg | Tablet | 4’s | Galaxy | Galaxy |